240 related articles for article (PubMed ID: 9769334)
1. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model.
Allaire E; Forough R; Clowes M; Starcher B; Clowes AW
J Clin Invest; 1998 Oct; 102(7):1413-20. PubMed ID: 9769334
[TBL] [Abstract][Full Text] [Related]
2. Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1.
Allaire E; Hasenstab D; Kenagy RD; Starcher B; Clowes MM; Clowes AW
Circulation; 1998 Jul; 98(3):249-55. PubMed ID: 9697825
[TBL] [Abstract][Full Text] [Related]
3. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis.
Tanney DC; Feng L; Pollock AS; Lovett DH
Dev Dyn; 1998 Sep; 213(1):121-9. PubMed ID: 9733107
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 beta induces differential gene expression in aortic smooth muscle cells.
Keen RR; Nolan KD; Cipollone M; Scott E; Shively VP; Yao JS; Pearce WH
J Vasc Surg; 1994 Nov; 20(5):774-84; discussion 784-6. PubMed ID: 7966813
[TBL] [Abstract][Full Text] [Related]
5. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
[TBL] [Abstract][Full Text] [Related]
6. Paracrine effect of vascular smooth muscle cells in the prevention of aortic aneurysm formation.
Allaire E; Muscatelli-Groux B; Mandet C; Guinault AM; Bruneval P; Desgranges P; Clowes A; Méllière D; Becquemin JP
J Vasc Surg; 2002 Nov; 36(5):1018-26. PubMed ID: 12422114
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow mesenchymal stem cells stabilize already-formed aortic aneurysms more efficiently than vascular smooth muscle cells in a rat model.
Schneider F; Saucy F; de Blic R; Dai J; Mohand F; Rouard H; Ricco JB; Becquemin JP; Gervais M; Allaire E
Eur J Vasc Endovasc Surg; 2013 Jun; 45(6):666-72. PubMed ID: 23598054
[TBL] [Abstract][Full Text] [Related]
8. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitous elevation of matrix metalloproteinase-2 expression in the vasculature of patients with abdominal aneurysms.
Goodall S; Crowther M; Hemingway DM; Bell PR; Thompson MM
Circulation; 2001 Jul; 104(3):304-9. PubMed ID: 11457749
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases. Their role in degenerative chronic diseases of abdominal aorta.
Palombo D; Maione M; Cifiello BI; Udini M; Maggio D; Lupo M
J Cardiovasc Surg (Torino); 1999 Apr; 40(2):257-60. PubMed ID: 10350113
[TBL] [Abstract][Full Text] [Related]
11. In situ localization and quantification of seventy-two-kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta.
McMillan WD; Patterson BK; Keen RR; Pearce WH
J Vasc Surg; 1995 Sep; 22(3):295-305. PubMed ID: 7674473
[TBL] [Abstract][Full Text] [Related]
12. Abdominal Aortic Aneurysm-Associated MicroRNA-516a-5p Regulates Expressions of Methylenetetrahydrofolate Reductase, Matrix Metalloproteinase-2, and Tissue Inhibitor of Matrix Metalloproteinase-1 in Human Abdominal Aortic Vascular Smooth Muscle Cells.
Chan CYT; Cheuk BLY; Cheng SWK
Ann Vasc Surg; 2017 Jul; 42():263-273. PubMed ID: 28288890
[TBL] [Abstract][Full Text] [Related]
13. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial.
Thompson RW; Baxter BT
Ann N Y Acad Sci; 1999 Jun; 878():159-78. PubMed ID: 10415728
[TBL] [Abstract][Full Text] [Related]
14. Localization of matrix metalloproteinase 2 within the aneurysmal and normal aortic wall.
Crowther M; Goodall S; Jones JL; Bell PR; Thompson MM
Br J Surg; 2000 Oct; 87(10):1391-400. PubMed ID: 11044166
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo.
Forough R; Koyama N; Hasenstab D; Lea H; Clowes M; Nikkari ST; Clowes AW
Circ Res; 1996 Oct; 79(4):812-20. PubMed ID: 8831505
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms.
Elmore JR; Keister BF; Franklin DP; Youkey JR; Carey DJ
Ann Vasc Surg; 1998 May; 12(3):221-8. PubMed ID: 9588507
[TBL] [Abstract][Full Text] [Related]
17. Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908).
Moore G; Liao S; Curci JA; Starcher BC; Martin RL; Hendricks RT; Chen JJ; Thompson RW
J Vasc Surg; 1999 Mar; 29(3):522-32. PubMed ID: 10069917
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells.
Janowska-Wieczorek A; Marquez LA; Matsuzaki A; Hashmi HR; Larratt LM; Boshkov LM; Turner AR; Zhang MC; Edwards DR; Kossakowska AE
Br J Haematol; 1999 May; 105(2):402-11. PubMed ID: 10233411
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of remodelling enzymatic activity induced by an angiotensin-converting enzyme inhibitor (perindopril) reduces the degeneration of experimental abdominal aortic aneurysms in a rat model.
Alsac JM; Journe C; Louedec L; Dai J; Julia P; Fabiani JN; Michel JB
Eur J Vasc Endovasc Surg; 2011 Apr; 41(4):474-80. PubMed ID: 21256058
[TBL] [Abstract][Full Text] [Related]
20. A nonintrinsic regional basis for increased infrarenal aortic MMP-9 expression and activity.
Ailawadi G; Knipp BS; Lu G; Roelofs KJ; Ford JW; Hannawa KK; Bishop K; Thanaporn P; Henke PK; Stanley JC; Upchurch GR
J Vasc Surg; 2003 May; 37(5):1059-66. PubMed ID: 12756355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
